This report aims to provide a comprehensive presentation of the global market for Cancer Genomic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genomic Testing. This report contains market size and forecasts of Cancer Genomic Testing in global, including the following market information:
Global Cancer Genomic Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Genomic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Breast Cancer Genomic Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Genomic Testing include Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience and Bio-Rad Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Genomic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Genomic Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Genomic Testing Market Segment Percentages, by Type, 2022 (%)
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
Global Cancer Genomic Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Genomic Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
Global Cancer Genomic Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Genomic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Genomic Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Genomic Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Genomic Testing, market overview.
Chapter 2: Global Cancer Genomic Testing market size in revenue.
Chapter 3: Detailed analysis of Cancer Genomic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Genomic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Genomic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genomic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genomic Testing Overall Market Size
2.1 Global Cancer Genomic Testing Market Size: 2022 VS 2029
2.2 Global Cancer Genomic Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genomic Testing Players in Global Market
3.2 Top Global Cancer Genomic Testing Companies Ranked by Revenue
3.3 Global Cancer Genomic Testing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genomic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Genomic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genomic Testing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genomic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genomic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Genomic Testing Market Size Markets, 2022 & 2029
4.1.2 Breast Cancer Genomic Testing
4.1.3 Lung Cancer Genomic Testing
4.1.4 Blood Cancer Genomic Testing
4.1.5 Liver Cancer Genomic Testing
4.1.6 Stomach Cancer Genomic Testing
4.1.7 Others
4.2 By Type - Global Cancer Genomic Testing Revenue & Forecasts
4.2.1 By Type - Global Cancer Genomic Testing Revenue, 2018-2023
4.2.2 By Type - Global Cancer Genomic Testing Revenue, 2024-2029
4.2.3 By Type - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genomic Testing Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Laboratories
5.1.5 Academic and Research Institutes
5.1.6 Others
5.2 By Application - Global Cancer Genomic Testing Revenue & Forecasts
5.2.1 By Application - Global Cancer Genomic Testing Revenue, 2018-2023
5.2.2 By Application - Global Cancer Genomic Testing Revenue, 2024-2029
5.2.3 By Application - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Genomic Testing Market Size, 2022 & 2029
6.2 By Region - Global Cancer Genomic Testing Revenue & Forecasts
6.2.1 By Region - Global Cancer Genomic Testing Revenue, 2018-2023
6.2.2 By Region - Global Cancer Genomic Testing Revenue, 2024-2029
6.2.3 By Region - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Genomic Testing Revenue, 2018-2029
6.3.2 US Cancer Genomic Testing Market Size, 2018-2029
6.3.3 Canada Cancer Genomic Testing Market Size, 2018-2029
6.3.4 Mexico Cancer Genomic Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Genomic Testing Revenue, 2018-2029
6.4.2 Germany Cancer Genomic Testing Market Size, 2018-2029
6.4.3 France Cancer Genomic Testing Market Size, 2018-2029
6.4.4 U.K. Cancer Genomic Testing Market Size, 2018-2029
6.4.5 Italy Cancer Genomic Testing Market Size, 2018-2029
6.4.6 Russia Cancer Genomic Testing Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Genomic Testing Market Size, 2018-2029
6.4.8 Benelux Cancer Genomic Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Genomic Testing Revenue, 2018-2029
6.5.2 China Cancer Genomic Testing Market Size, 2018-2029
6.5.3 Japan Cancer Genomic Testing Market Size, 2018-2029
6.5.4 South Korea Cancer Genomic Testing Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Genomic Testing Market Size, 2018-2029
6.5.6 India Cancer Genomic Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Genomic Testing Revenue, 2018-2029
6.6.2 Brazil Cancer Genomic Testing Market Size, 2018-2029
6.6.3 Argentina Cancer Genomic Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genomic Testing Revenue, 2018-2029
6.7.2 Turkey Cancer Genomic Testing Market Size, 2018-2029
6.7.3 Israel Cancer Genomic Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Genomic Testing Market Size, 2018-2029
6.7.5 UAE Cancer Genomic Testing Market Size, 2018-2029
7 Cancer Genomic Testing Companies Profiles
7.1 Myriad Genetics
7.1.1 Myriad Genetics Company Summary
7.1.2 Myriad Genetics Business Overview
7.1.3 Myriad Genetics Cancer Genomic Testing Major Product Offerings
7.1.4 Myriad Genetics Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.1.5 Myriad Genetics Key News & Latest Developments
7.2 Centogene AG
7.2.1 Centogene AG Company Summary
7.2.2 Centogene AG Business Overview
7.2.3 Centogene AG Cancer Genomic Testing Major Product Offerings
7.2.4 Centogene AG Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.2.5 Centogene AG Key News & Latest Developments
7.3 Color Genomics
7.3.1 Color Genomics Company Summary
7.3.2 Color Genomics Business Overview
7.3.3 Color Genomics Cancer Genomic Testing Major Product Offerings
7.3.4 Color Genomics Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.3.5 Color Genomics Key News & Latest Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Company Summary
7.4.2 Quest Diagnostics Business Overview
7.4.3 Quest Diagnostics Cancer Genomic Testing Major Product Offerings
7.4.4 Quest Diagnostics Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.4.5 Quest Diagnostics Key News & Latest Developments
7.5 23andMe Inc.
7.5.1 23andMe Inc. Company Summary
7.5.2 23andMe Inc. Business Overview
7.5.3 23andMe Inc. Cancer Genomic Testing Major Product Offerings
7.5.4 23andMe Inc. Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.5.5 23andMe Inc. Key News & Latest Developments
7.6 Gene By Gene Ltd.
7.6.1 Gene By Gene Ltd. Company Summary
7.6.2 Gene By Gene Ltd. Business Overview
7.6.3 Gene By Gene Ltd. Cancer Genomic Testing Major Product Offerings
7.6.4 Gene By Gene Ltd. Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.6.5 Gene By Gene Ltd. Key News & Latest Developments
7.7 LabCorp
7.7.1 LabCorp Company Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Cancer Genomic Testing Major Product Offerings
7.7.4 LabCorp Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.7.5 LabCorp Key News & Latest Developments
7.8 Positive Bioscience
7.8.1 Positive Bioscience Company Summary
7.8.2 Positive Bioscience Business Overview
7.8.3 Positive Bioscience Cancer Genomic Testing Major Product Offerings
7.8.4 Positive Bioscience Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.8.5 Positive Bioscience Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Company Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Cancer Genomic Testing Major Product Offerings
7.9.4 Bio-Rad Laboratories Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 Illumina, Inc.
7.10.1 Illumina, Inc. Company Summary
7.10.2 Illumina, Inc. Business Overview
7.10.3 Illumina, Inc. Cancer Genomic Testing Major Product Offerings
7.10.4 Illumina, Inc. Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.10.5 Illumina, Inc. Key News & Latest Developments
7.11 Agilent Technologies
7.11.1 Agilent Technologies Company Summary
7.11.2 Agilent Technologies Business Overview
7.11.3 Agilent Technologies Cancer Genomic Testing Major Product Offerings
7.11.4 Agilent Technologies Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.11.5 Agilent Technologies Key News & Latest Developments
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Company Summary
7.12.2 Thermo Fisher Scientific Business Overview
7.12.3 Thermo Fisher Scientific Cancer Genomic Testing Major Product Offerings
7.12.4 Thermo Fisher Scientific Cancer Genomic Testing Revenue in Global Market (2018-2023)
7.12.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Genomic Testing Market Opportunities & Trends in Global Market
Table 2. Cancer Genomic Testing Market Drivers in Global Market
Table 3. Cancer Genomic Testing Market Restraints in Global Market
Table 4. Key Players of Cancer Genomic Testing in Global Market
Table 5. Top Cancer Genomic Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Genomic Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Genomic Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Genomic Testing Product Type
Table 9. List of Global Tier 1 Cancer Genomic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genomic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Genomic Testing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Genomic Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Genomic Testing Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Genomic Testing Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Genomic Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Genomic Testing Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Genomic Testing Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Genomic Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Genomic Testing Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Genomic Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Genomic Testing Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Genomic Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Genomic Testing Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Genomic Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Genomic Testing Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Genomic Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Genomic Testing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Genomic Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Genomic Testing Revenue, (US$, Mn), 2024-2029
Table 30. Myriad Genetics Company Summary
Table 31. Myriad Genetics Cancer Genomic Testing Product Offerings
Table 32. Myriad Genetics Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Myriad Genetics Key News & Latest Developments
Table 34. Centogene AG Company Summary
Table 35. Centogene AG Cancer Genomic Testing Product Offerings
Table 36. Centogene AG Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Centogene AG Key News & Latest Developments
Table 38. Color Genomics Company Summary
Table 39. Color Genomics Cancer Genomic Testing Product Offerings
Table 40. Color Genomics Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Color Genomics Key News & Latest Developments
Table 42. Quest Diagnostics Company Summary
Table 43. Quest Diagnostics Cancer Genomic Testing Product Offerings
Table 44. Quest Diagnostics Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Quest Diagnostics Key News & Latest Developments
Table 46. 23andMe Inc. Company Summary
Table 47. 23andMe Inc. Cancer Genomic Testing Product Offerings
Table 48. 23andMe Inc. Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 49. 23andMe Inc. Key News & Latest Developments
Table 50. Gene By Gene Ltd. Company Summary
Table 51. Gene By Gene Ltd. Cancer Genomic Testing Product Offerings
Table 52. Gene By Gene Ltd. Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Gene By Gene Ltd. Key News & Latest Developments
Table 54. LabCorp Company Summary
Table 55. LabCorp Cancer Genomic Testing Product Offerings
Table 56. LabCorp Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 57. LabCorp Key News & Latest Developments
Table 58. Positive Bioscience Company Summary
Table 59. Positive Bioscience Cancer Genomic Testing Product Offerings
Table 60. Positive Bioscience Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Positive Bioscience Key News & Latest Developments
Table 62. Bio-Rad Laboratories Company Summary
Table 63. Bio-Rad Laboratories Cancer Genomic Testing Product Offerings
Table 64. Bio-Rad Laboratories Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Bio-Rad Laboratories Key News & Latest Developments
Table 66. Illumina, Inc. Company Summary
Table 67. Illumina, Inc. Cancer Genomic Testing Product Offerings
Table 68. Illumina, Inc. Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Illumina, Inc. Key News & Latest Developments
Table 70. Agilent Technologies Company Summary
Table 71. Agilent Technologies Cancer Genomic Testing Product Offerings
Table 72. Agilent Technologies Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 73. Agilent Technologies Key News & Latest Developments
Table 74. Thermo Fisher Scientific Company Summary
Table 75. Thermo Fisher Scientific Cancer Genomic Testing Product Offerings
Table 76. Thermo Fisher Scientific Cancer Genomic Testing Revenue (US$, Mn) & (2018-2023)
Table 77. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Cancer Genomic Testing Segment by Type in 2022
Figure 2. Cancer Genomic Testing Segment by Application in 2022
Figure 3. Global Cancer Genomic Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Genomic Testing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Genomic Testing Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2022
Figure 8. By Type - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Genomic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Genomic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 16. US Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 28. China Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Genomic Testing Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Genomic Testing Revenue, (US$, Mn), 2018-2029
Figure 41. Myriad Genetics Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Centogene AG Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Color Genomics Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Quest Diagnostics Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. 23andMe Inc. Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gene By Gene Ltd. Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LabCorp Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Positive Bioscience Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bio-Rad Laboratories Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Illumina, Inc. Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Agilent Technologies Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Thermo Fisher Scientific Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
